Another area in which PEDF has shown potential in anticancer therapy is the suppression of cancer stem cells (CSCs) growth and differentiation, which makes tumors more sensitive to standard therapies and reduces the likelihood of disease recurrence [104]. Here, SERPINF1 is linked to cancer.